Related Experiment Video
Updated: Jul 11, 2025

Microelectrode Array Recording of Sinoatrial Node Firing Rate to Identify Intrinsic Cardiac Pacemaking Defects in Mice
Published on: July 5, 2021
Sinus node dysfunction and stroke risk: a systematic review and meta-analysis
Haoyu Dong1, Hao Chen1, Tesfaldet Habtemariam Hidru1
1Department of Cardiology, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
Insights
Patients with sinus node dysfunction (SND) face a similar stroke risk whether or not they have atrial fibrillation (AF). This highlights the need for stroke prevention strategies in all SND patients.
Area of Science:
- Cardiology
- Neurology
- Clinical Research
Background:
- The stroke risk associated with cardiac arrhythmia, particularly atrial fibrillation (AF), is well-established.
- However, the specific stroke risk in patients with sinus node dysfunction (SND), with or without co-existing AF, remains unclear.
- This study addresses this gap by comparing stroke risk in these patient groups.
Approach:
- A systematic review and meta-analysis was conducted using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach.
- Searches were performed across PubMed, EMBASE, and Cochrane databases up to December 2022.
- Included studies focused on stroke incidence in patients diagnosed with SND, both with and without AF/atrial flutter.
Key Points:
- Analysis of 6 papers involving 106,163 patients revealed an average yearly stroke incidence of 1.542% in the SND population.
- Stroke incidence was comparable between isolated SND (1.587%) and SND with AF (1.660%).
- Factors associated with increased stroke risk in SND patients included AF, prior thrombotic events, hypertension, and heart failure.
Conclusions:
- Patients with SND exhibit a similar stroke risk, irrespective of the presence or absence of atrial fibrillation.
- These findings underscore the importance of considering stroke prevention measures for all individuals with SND.
- Further research is warranted to evaluate the efficacy of interventions like anticoagulation therapy for stroke prevention in the SND population.
Objectives:
The role of cardiac arrhythmia in ischaemic stroke is widely studied, but the size of the stroke risk in patients with sinus node dysfunction (SND) with and without atrial fibrillation (AF) is unclear. This systematic review and meta-analysis aimed to compare the risk of stroke and its associated factors in patients with SND with and without AF.
Design:
A systematic review and meta-analysis was conducted based on the Grading of Recommendations, Assessment, Development and Evaluation approach.
Data Sources:
PubMed, EMBASE and Cochrane Database were searched until December 2022.
Eligibility Criteria For Selecting Studies:
Studies that investigate stroke in patients with SND diagnosed with or without AF/atrial flutter.
Data Extraction And Synthesis:
Two independent authors screened studies for inclusion and extracted data. Literature quality assessment was performed using the Newcastle-Ottawa Scale and the Cochrane Collaboration Tool. The overall risk of stroke was estimated using the random-effects model. The generic inverse variance method was used to calculate the pooled estimates of stroke-associated factors. We performed a sensitivity analysis using a fixed-effects model.
Results:
Of the 929 records retrieved, 6 papers (106 163 patients) met the inclusion criteria. The average yearly stroke incidence in patients with SND was 1.542% (95% CI: 1.334% to 1.749%). The stroke incidence was similar between the isolated SND (1.587%; 95% CI: 1.510% to 1.664%) and non-isolated (SND+AF) (1.660%; 95% CI: 0.705% to 2.615%) groups. AF (HR, 95% CI: 1.53 (1.01 to 2.33)), stroke/transient ischaemia attack/other thrombotic events (HR, 95% CI: 2.54 (1.14 to 5.69)), hypertension (HR, 95% CI: 1.51 (1.11 to 2.07)) and heart failure (HR, 95% CI: 1.41 (1.01 to 1.97)) were associated with stroke in the SND population.
Conclusion:
Our findings suggest that patients with SND carry a similar risk of stroke to those with combined SND and AF. Future studies are needed to investigate whether interventions targeting stroke prevention, such as anticoagulation therapy, can help to prevent stroke in patients with SND.
Prospero Registration Number:
CRD42023408436.
Related Concept Videos
ECG Interpretation of Arrhythmias I: Sinus Arrhythmias
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism,...
Decreased pulse rate
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Mitral Stenosis IV: Nursing Management
Dysrhythmias I: Introduction

